- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03338088
Evaluation of Adherence to Clinical Treatment of Glaucoma
November 19, 2017 updated by: Instituto de Olhos de Goiania
Evaluation of Adherence to Clinical Treatment of Glaucoma in Patients of a Reference Ophthalmological Hospital in Goiânia
Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia using Morisky Adhesion scale as a validated questionary.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Actual)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
GO
-
Goiania, GO, Brazil, 74120-050
- Instituto de Olhos de Goiania
-
-
Goias
-
Goiânia, Goias, Brazil, 74110120
- Instituto de Olhos de Goiania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 100 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All pacients that have glaucoma diagnosed that respond the questionary
Description
Inclusion Criteria: have glaucoma diagnosed -
Exclusion Criteria: not having glaucoma diagnosed
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia
Time Frame: 2 months
|
evaluation of the scale
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Joao jr Nassaralla, coordinator, Coordinator
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Actual)
November 6, 2017
Study Completion (Anticipated)
December 30, 2017
Study Registration Dates
First Submitted
November 7, 2017
First Submitted That Met QC Criteria
November 7, 2017
First Posted (Actual)
November 9, 2017
Study Record Updates
Last Update Posted (Actual)
November 21, 2017
Last Update Submitted That Met QC Criteria
November 19, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INSTITUTO DE OLHOS-MAYRA 2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma; Drugs
-
Sheba Medical CenterRecruitingGlaucoma | Glaucoma; DrugsIsrael
-
wangdaboUnknown
-
Intuor Technologies, Inc.Unknown
-
CT Glaucoma AssociatesTerminatedGlaucoma, Open-Angle | Glaucoma; DrugsUnited States
-
Democritus University of ThraceCompletedGlaucoma | Ocular Surface Disease | Glaucoma; DrugsGreece
-
Glostrup University Hospital, CopenhagenCompleted
-
Wills EyeOptovueCompletedPrimary Open-angle Glaucoma | Normal Tension Glaucoma | Glaucoma; DrugsUnited States
-
Benha UniversityRecruitingHypertension | Glaucoma, Angle-Closure | Glaucoma Suspect | Glaucoma Secondary to Drugs, BilateralEgypt
-
Tulane UniversityNot yet recruitingGlaucoma | Glaucoma, Open-Angle | Ptosis | Glaucoma, Primary Open Angle | Glaucoma; Drugs | Droopy EyelidUnited States
-
Dr. Kaweh MansouriEnrolling by invitationGlaucoma, Angle-Closure | Surgery | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma; Drugs | Glaucoma, Pigmentary | Glaucoma Secondary | Glaucoma Open-Angle | Glaucoma Congenital | Glaucoma CapsulareSwitzerland